Although blood ULBP1 was significantly higher in patients with HCC, its applicability as an HCC screening tool was diminished by the fact that it was also detectable to varying degrees in HBV-related diseases without HCC (Cosman et al., 2001). Here, ULBP1 is linked to hepatocellular carcinoma.